Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant has been dominant in Europe since January 2022, causing large waves of infections because of high transmissibility and escape from vaccine- and infection-induced immunity.
Current COVID-19 situation and what's next for COVID-19
WHO's Information Network for Epidemics organised a webinar to provide an update on the current COVID-19 situation, the new variants, and discuss what it means for the pandemic and our lives.